study tip gal

320 flashcardsby hikaru
Study these flashcardsFree · spaced repetition · iPhone, Android, Mac & web

First 300 of 320 cards

1
Daily Patches
Daytrana (QAM 2h before school)
Nicoderm
Exelon
Neupro
Emsam
Androderm (nightly)
Daily Patches
2
(Special Instructions)
Lidoderm (1-3 on for 12 h - 12 h off)
Nitroglycerin (on for 12-14 h - 10-12 h off)
3
Twice Daily Patches
Flector
4
Twice Weekly Patches
Alora, Vivelle-Dot
Oxytrol
5
Weekly Patches
Butrans
Catapres-TTS
Climara, Menostar
ClimaraPro
Xulane (qwk for 3 wks - 1 wk off)
6
Other Patch Durations
Duragesic (q72h or q48h)
Transderm Scop (q72h)
7
National Patient Safety Goals
2 patient identifiers (name, DOB, MRN)

Report critical test results

Label all medications

Anticoagulant therapy safety measures

Med information (med rec + D/C counseling)

Prevent HC-associated infections

CDC hand hygiene
8
Penicillin Allergy AND Syphilis in Pregnancy or HIV
Must test, and if positive, desensitize

PCN is the only acceptable treatment
9
Penicillin Allergy and AOM
May use 2nd or 3rd gen cephalosporin

Cefdinir, Cefpodoxime, Ceftriaxone, Cefuroxime
10
Testing HLA-B*5701
Abacavir

If (+) --> risk of fatal hypersensitivity
(Test ALL patients prior)
11
Testing HLA-B*5801
Allopurinol

If (+) --> risk of SJS
(Consider testing in Korean + renal impairment, Han, or Thai)
12
Testing HLA-B*1502
Carbamazepine, Oxcarbazepine, Phenytoin

If (+) --> risk of SJS/TEN
(Test all Asian pts prior to Carbamazepine)
13
Testing CYP2C19
Clopidogrel

If *2 or *3 --> Poor metabolizers
(consider alt tx)
14
Testing CYP2D6
Codeine

Ultra-rapid --> risk of OD
15
Testing CYP2C9 + VKORC1
Warfarin

If CYP*2 or *3 or VKOR G>A --> increased bleeding risk
(start with lower dose)
16
Testing HER2
Trastuzumab

HER2 (-) --> drug not effective
17
Testing KRAS
Cetuximab

If KRAS (+) --> Do not use
18
Testing TPMT
Azathioprine

TPMT activity low/absent --> risk of myelosuppression
(Use lower dose or consider alt tx)
19
Testing DPD
Capecitabine, Fluorouracil

If DPD deficient --> risk of toxicity
(Do not use)
20
Common Symptomatic Treatment in Toxic OD
Agitation - Sedatives (BZDs)
Bradycardia - Atropine, inotropes
Seizure - BZDs
Hypertension - IV vasodilator
Hypoglycemia - Dextrose
Hypotension - IVF, vasopressors
QRS widening - Sodium bicarb
Sedation - Intubation
21
Oral NAC Dosing
140 mg/kg x 1
70 mg/kg q4h x 17

(Repeat dose if emesis w/i 1 h of dose)
22
Acetadote Dosing
150 mg/kg over 60 min
50 mg/kg over 4 h
100 mg/kg over 16 h
23
Drugs that use GFR for Dosing
Metformin
SGLT2 Inhibitors
24
Cockroft-Gault Weights
<IBW --> TBW

Normal weight --> IBW

OW/Obese --> AdBW
25
ACEI/ARBs for Albuminuria
WHO - All pts w/ albuminuria
WHY - Prevent KD progression
HOW - Inhibit RAAS --> efferent arteriole dilation
WHAT - Dec. pressure in glomerulus, dec. albuminuria, CV protection
26
Hyperkalemia Tx
CA BIG K Drop

Stabilize - Ca gluconate

Move it - Albuterol, Bicarb, Insulin, Glucose

Remove it - Kayexelate, Furosemide, Patiromer, Dialysis
27
Hepatitis A
Acute
Fecal-Oral
Vaccine

Tx - Supportive
28
Hepatitis B
Acute + Chronic
Blood, body fluid
Vaccine

Tx - PEG-INF or NRTI (tenofovir, entecavir)
29
Hepatitis C
Acute + Chronic
Blood, body fluid
NO vaccine

Tx-naive - DAA combo
(select pts - DAAs + RBV or DAAs + RBV + PEG-INF)
30
NS3/4A Protease Inhibitors
-previr

(P for PI)
31
NS5A Replication Complex Inhibitors
-asvir

(A for NS5A)
32
NS5B Polymerase Inhibitors
-buvir

(B for NS5B)
33
Protease Inhibitors and Food
PIG (Protease Inhibitors + Grub)

TAKE WITH FOOD
(except elbasvirrazoprevir and fosamprenavir PO susp)
34
Acid Suppressive Therapy should be avoided with these HCV drugs:
Harvoni
Epclusa
Vosevi
35
Interferon-alfa
HBV, HCV
Some cancers

(No cure and not well tolerated)
36
Interferon-beta
Multiple Sclerosis
37
HBV NRTIs
Honey, Bring Vi a LATTE

Lamivudine
Adefovir
TDF
TAF
Entecavir
38
LFTs in Alcoholic Liver Disease
AST = 2x ALT
39
Chronic Liver Disease Labs
Inc. AST/ALT, Alk Phos, Tbili, LDH, INR

Dec. Albumin
40
Acute Liver Toxicity Labs
Inc. AST/ALT
41
General Rules for All Vaccines
Usually can be given at same time/visit

Multiple live vaccines given on SAME DAY or spaced 4 wks
42
If vaccine series intervals must be changed...
It is better to extend rather than shorten
43
Exceptions to General Vaccine Rules
WIth Asplenia, Prevnar and Menactra separated by 4 weeks

No separation required for PO rotavirus vaccines
44
Live Vaccines and Antibody
Vaccines -- 2 weeks --> Ab product

Ab product -- 3 months --> vaccine

Simultaneous administration of both is rec for PEP of Hep A, Hep B, rabies, tetanus
45
Invalid Contraindications to Vaccination
Mild illness
Current Abx therapy
Previous local skin reaction (mild/mod)
Allergies: Bird feathers, PCN
Pregnancy (EXCEPT LIVE VACCINES)
Recent PPD
Immunosuppressed person in household
FH of ADR to vaccine
46
Causes of Immunodeficiency (Vaccination)
Chemo/Transplant drugs
Immunosuppressant drugs for AI disease
HIV with CD4 <200
Systemic steroids for 14+ days at >20 mg pred qd
Chronic renal failure
47
Influenza Vaccine: Age 6 mo to 8 years (not previously vaccinated)
GIve 2 doses (4 weeks apart)
48
Influenza Vaccine in Patients with an Egg Allergy
May receive any INACTIVATED vaccine (avoid live)

Pt should be supervised for 15 min after vaccine

Flublok is egg-free but only for age 18+
49
Influenza Vaccines only for Ages 65+
Fluzone High-Dose
Fluad
50
PCV13 Indications
(Pts should only receive 1 dose or childhood series in life)

Give 1 dose if never received:
IC pts age 6-64 years
Anyone age 65+
51
PPSV23 Indications
Give 1 dose before 65 years:
DM, heart, lung or liver disease, alcoholism, smokers

Give 2 doses before 65 years:
IC pts age 2-64

Give 1 dose at age 65+ years
All pts (whether or not 0-2 doses received before)
52
Vaccines stored in the Freezer
Varicella
Zostacax
MMRV
Oral Cholera
53
SC Only Vaccines
MMR, MMRV
Varicella, Zostavax
Yellow Fever
54
IM or SC Vaccines
PPSV23
55
PO Vaccines
Typhoid - caps
Cholera - sol
Rotavirus - sol
56
Drugs for Travelers' Diarrhea (Prophylaxis)
BSS 524-1050 mg PO QID

Abx (RIFAMIXIN / rifamycin or quinolones if low resistance)
57
Drugs for Travelers' Diarrhea (Treatment)
MILD
Loperamide PRN

MOD
Loperamide PRN +/- Abx

SEVERE (INCLUDING DYSENTERY)
Azithromycin 1,000 mg x 1 +/- Loperamide
58
Common Resistant Pathogens
Kill Each And Every Strong Pathogen

Klebsiella pneumoniae (ESBL, CRE)
Escherichia coli (ESBL, CRE)
Acinetobacter baumannii
Enterococcus faecalis/faecium (VRE)
Staph aureus (MRSA)
Pseudomonas aeruginosa
59
INSTI-based Regimens preferred for Initial Tx
BIKTARVY
(bictegravir/emtricitabine/TAF)
TRIUMEQ
(dolutegravir/abacavir/lamivudine)
TIVICAY + TRUVADA
(dolutegravir + emtricitabine/TDF)
TIVICAY + DESCOVY
(dolutegravir + emtricitabine/TAF)
ISENTRESS + TRUVADA
(raltegravir + emtricitabine/TDF)
ISENTRESS + DESCOVY
(dolutegravir + emtricitabine/TAF)
60
Comments on Initial HIV Regimens
Abacavir requires HLA-B*5701 testing
Use TDF with caution in renal insufficiency
Lamivudine and Emtricitabine = interchangeable

Single tablet regimens cannot be renally adjusted:
Do not start Triumeq at CrCl <50
Do not start Biktarvy at CrCl <30
61
Key Features of NRTIs
Renal dose adjustment requires (except abacavir)

No CYP DDI

No regard to meals (except didanosine)

WARNING: lactic acidosis + steatosis
(zidovudine, stavudine, didanosine > others)

TeNOFovir - Nephtotoxic, Osteoporosis, Fanconi
(TAF has less ADRs)
62
Key Features of NNRTIs
No renal dose adjustment
(Avoid Complera + Atripla if CrCl <50)

Primarily CYP inducers
(efavirenz is induce > inhibit; rilpi + dora are substrates)

Hepatotoxicity + Rash (SJS/TEN) [Nevira > others]

W/ Food: Etra; Rilpi
W/O Food: Efavirenz

Efavirenz - CNS effects; give QHS on empty stomach
Rilpi - QT prolong; depression/suicidality
Key Features of PIs
63
(-navir)
Primarily CYP inhibitors
Taken with PK booster (rotinavir or cobicistat)
No renal dose adjustments

HEPATOtoxicity (highest with tipranavir)
Rash (SJS/TEN)

METABOLIC ABNORMALITIES
Hyperglycemia (highest with indina, lopin / rito)
Lipohypertrophy (ataza, daruna < other PIs)

CVD risk (ataza, daruna < other PIs)

GI upset - take w/ food (EXCEPT fosam + lopin / rito)

Bleeding events (pts w/ hemophilia)

ECG changes (saquin / rito, lopin / rito, ataza / rito)
64
Drugs Contraindicated with Ritonavir and Cobicistat
Alfuzosin
Amiodarone
Dronedarone
Carbamazepine
Phenobarbital
Phenytoin
Rifampin
St. John's
Lovastatin
Simvastatin
Key Features of INSTIs
65
(-tegravir)
No renal dose adjustment
Do not start Stribild if CrCl <70
Do not start Biktarvy/Genvoya if CrCl <30

No major CYP DDIs
Interacts with polyvalent ions

Inc. CPK (Ralte > others)

HA, Insomnia
66
HIV Meds taken WITH Food
PIs (except fosamprenavir suspension)

Genvoya
Stribild
Rilpivirine (+ combos)
Etravirine (after meals)
Symtuza
Tenofovir powder
Cobicistat
67
HIV Meds taken WITHOUT food
Atripla
Efavirenz (+ combos)
Symfi + Symfi Lo
Fosamprenavir suspension
Didanosine
Indinavir (unboosted)
68
NRTIs Class Effect
Lactic Acidosis
69
Abacavir ADRs
Hypersensitivity + Inc risk of MI
70
Didanosine ADRs
Pancreatitis + Peripheral Neuropathy
71
Emtricitabine ADRs
HA
72
Lamivudine ADRs
HA
73
Stavudine ADRs
Pancreatitis + Peripheral Neuropathy
74
Tenofovir ADRs
Nephrotoxicity (Fanconi) + Dec. BMD
75
Zidovudine ADRs
MACROcytic anemia + Myopathy
76
NNRTIs Class Effect
Rash
77
Efavirenz ADRs
CNS effects
78
Nevirapine ADRs
Hepatotoxicity + Hypersensitivity
79
Etravirine ADRs
SJS/TEN
80
Doravirine ADRs
Hepatotoxicity
81
Rilpivirine ADRs
Depression + Insomnia
82
PIs Class Effects
Metabolic abnormalities + NVD
83
Darunavir ADRs
HA
84
Atazanavir ADRs
Nephrolithiasis + Indirect hyperbili
85
Fosamprenavir ADRs
Rash
86
Indinavir ADRs
Nephrolithiasis + Urolithiasis
87
Lopinavir/Ritonavir ADRs
HyperTG
88
Nelfinavir ADRs
Diarrhea
89
Ritonavir ADRs
NVD
90
Saquinavir ADRs
Nausea
91
Tipranivir ADRs
Intracranial hemorrhage
92
Bictegravir ADRs
HA
93
Raltegravir ADRs
Inc. CPK, Myopathy, Rhabdomyolysis
94
Elvitegravir ADRs
HA + Insomnia
95
Dolutegravir
Inc. SCr w/o affecting GFR
96
ASCVD RIsk Score is not needed in these patients:
Clinical ASCVD
Diabetes
LDL >190
97
Secondary Prevention with Clinical ASCVD
High-Intensity Statin
98
Primary Prevention with LDL >190
High-Intensity Statin
99
Primary Prevention with Diabetes, age 40-75 and LDL between 70-189
MULTIPLE ASCVD RF
High-Intensity Statin

REGARDLESS OF ASCVD RISK
Mod-Intensity
100
Primary Prevention with age 40-75 and LDL between 70-189
ASCVD RISK >20%
High-Intensity Statin

ASCVD RISK 7.5-19.9%
Mod-Intensity Statin
101
Statin Equivalent Doses
Pharmacists Rock At Saving Lives + Preventing Fatty-D

Pitava - 2
Rosuva - 5
Aorva - 10
Simva - 20
Lova - 40
Prava - 40
Fluva - 80
102
Reduce the Risk of Statin Myalgias
Avoid DDIs
Do not use Simvastatin 80 mg/day
Do not use Gemfibrozil + Statin
103
Managing Statin Myalgias
Hold statin, check CPK

After 2-4 weeks, re-challenge same statin or decrease dose

If myalgias return, D/C statin. Once myalgia resolves, use low dose of alt statin
104
Strong CYP3A4 Inhibitors to Avoid with Simvastatin and Lovastatin
Itra, Keto, Posa, Voriconazole
Erythro, Clarithromycin
HIV PI
Cobicistat
Nefazodone
Cyclosporine
Danazol
Grapefruit Juice
When to Add-On Non-Statin Treatment
105
(Ezetimibe or PCSK9-I)
Very-high risk + LDL >70
Primary Hyperchol + LDL >100
106
When to start HTN Medications
Stage 2 HTN

Stage 1 HTN PLUS:
Clinical CVD (stroke, HF, CHD)
ASCVD risk >10%
107
BP Goals for HTN
<130/80

(ADA says <130/80 for ASCVD risk and <140/90 for lower risk)
108
Initial HTN Meds for Non-Black Population
Thiazide, CCB, ACEI, ARB
109
Initial HTN Meds for Black Population
Thiazide, CCB
110
Initial HTN Meds for CKD
ACEI, ARB
111
Initial HTN Meds for DM + Albuminuria
ACEI, ARB
112
Initial HTN Meds for Stage 2 HTN (150/90)
Start 2 first-line agents
113
Pregnant patients with Chronic HTN should receive medications when:
BP = 160/105
114
Beta-1 Selective Blockers
AMEBBA
Atenolol
Metoprolol
Esmolol
Bisoprolol
Betaxolol
Acebutolol
115
Beta-1 Selective Blocker with NO Vasodilation
Nebivolol
116
Non-Selective Beta Blockers
Nadolol
Pindolol
Propranolol
Timolol
117
Non-selctive Beta and Alpha-1 Blockers
Carvedilol
Labetalol
118
Treatment Approach for SIHD
A - Antiplatelet + Antianginal drugs
B - BP + Beta Blockers
C - Cholesterol (statins) + Cigarette Cessation
D - Diet + Diabetes
E - Exercise + Education
119
Drug Treatment of ACS
MONA-GAP-BA

Morphine, O2, Nitrates, Aspirin

GPIIb/IIIa antagonists, Anticoagulants, P2Y12 Inhibitors

BB, ACEI

(NSTE-ACS = +/- PCI; STEMI = + PCI or fibrinolytic)
120
Drugs for Secondary Prevention of ACS
ASPIRIN
81 mg qd indefinitely

P2Y12I
Med Tx Pts - Tica/Clop + ASA for 12 mo (at least)
PCI Pts - Tica/Clop/Pras + ASA for 12 mo (at least)
[continuation considered at not high bleeding risk]

NTG
Indefinitely

BB
3 years (indefinite prn HF or HTN)

ACEI
Indefinitely is LVEF <40%, HTN, CKD, DM

ALDOSTERONE ANTAGONIST
Indefinitely if LVEF <40% + symptomatic HF or DM on ACEI + BB

STATIN
High-intensity
(consider Mod or High for age >75)
121
Labs in Systolic HF
Inc. BNP + NT-proBNP

(help distinguish between cardiac + non-cardiac causes of dyspnea)
122
General S/S in HF
Dyspnea (SOB at rest or exertion)
Cough
Fatigue, Weakness
Reduced exercise capacity
123
Left-sided S/S in HF
Orthopnea (SOB lying flat)
Paroxysmal Nocturnal Dyspnea
Bibasilar Rales
S3 Gallop
Hypoperfusion
124
Right-sided S/S in HF
Peripheral edema
Ascites
Jugular Venous Distension
Hepatojugular Reflux
Hepatomegaly
125
Drugs that decrease Mortality in HF
ACEI or ARB
Block RAAS --> vasodilation + inc EF

ARNI
In Sx HF where pt tolerates ACEI/ARB, ARNI is preferred to further dec. mortality

BB
Block SNS activation + dec arrhythmia risk

ALDOSTERONE ANTAGONISTS
Added diuresis
126
Drugs that decrease Mortality in HF (Special Pop)
Hydralazine + Nitrate (BiDil)

When added to Tx of Black pts w/ ACEI/ARB + BB or in pts who could not tolerate and ACEI/ARB
127
Drugs that Improve HF but do NOT decrease Mortality
LOOPS
Dec. edema

DIGOXIN
Inc. CO + Dec. hospitalizations

IVABRADINE
Dec. hospitalizations
128
An arrhythmia is caused by a disruption somewhere in the conduction system:
SA node can be firing at abnormal rate or rhythm
Scar tissue can block/divert signal transmission
Another part of the heart may be acting as pacemaker
129
Classifying Drugs with Vaughan Williams
Double Quarter Pounder, Lettuce, Mayo, Fries Please!
Because Dieting During Stress Is Always Very Difficult

CLASS I
Ia: Disopyramide, Quinidine, Procainamide
Ib: Lidocaine, Mexiletine
Ic: Flecainide, Propafenone

CLASS II - Beta Blockers

CLASS III
Dronedarone, Dofetilide, Sotalol, Ibutilide, Amiodarone

CLASS IV - Verapamil, Diltiazem
130
Rhythm Control in Afib
If Afib is permanent, avoid Rhythm Control (risk > benefit)
131
What pathway does Warfarin act on?
Intrinsic

FII, VII, IX, X
132
What pathway do UFH + LMWH work on?
Extrinsic (X --> Xa)

Common (Thrombin [IIa])
133
Conversion from Warfarin to DOAC
READ

Riva when INR <3
Edox when INR <2.5
Apix when INR <2
Dabig when INR <2
134
Conversion from Xa Inhibitor to Warfarin
Overlap Xa inhibitor until INR is therapeutic OR

Stop Xa inhibitor + start parenteral AC + Warfarin at next dose
135
Conversion from Dabigatran to Warfarin
Start Warfarin 1-3 days before stopping Dabigatran
136
Warfarin Tablet Colors
Please Let Greg Brown Bring Peaches To Your Wedding

Pink - 1
Lavender - 2
Green - 2.5
Brown - 3
Blue - 4
Peach - 5
Teal - 6
Yellow - 7.5
White - 10
137
Food high in Vitamin K
Broccoli
Brussel Sprouts
Cabbage
Kale, Lettuce, Greens
Spinach
Tea
138
Treat INR <4.5 w/o bleeding
Reduce or skip warfarin dose
139
Treat INR 4.5-10 w/o bleeding
Hold 1-2 doses of warfarin

(may use Vit K if urgent surgery necessary)
140
Treat INR >10 w/o bleeding
PO Vitamin K 2.3-5 mg
141
Treat Major Bleeding from Warfarin
IV Vitamin K 5-10 mg + 4F-PCC
142
CHADS-VASc
CHF
HTN
Age 75+ = 2
DM
Prior Stroke/TIA = 2
Vascular disease (MI, PAD, aortic plaque)
Age 65-74
Sex (female)
143
Lab Findings in Iron Deficiency Anemia
Dec. Hgb, MCV, reticulocytes
Dec. Fe, ferritin, TSAT

Inc. TIBC
144
Treatment of Iron Deficiency Anemia
100-200 mg elemental Fe/day
Take Fe on empty stomach
Avoid H2RAs + PPIs

SR or EC not rec for initial Tx
145
Goal in Iron Deficiency Anemia
Inc. Hgb by 1 q2-3 weeks
146
% Elemental Iron in PO Products
Gluconate - 12%
Sulfate - 20%
Fumarate - 33%
Carbonyl Iron - 100%
Polysaccharide - 100%
147
Uses of Diphenhydramine
Acute allergic rxns (+/- epinephrine)
Premed for allergic rxns
Allergic rhinitis
Cough
Sleep
Dystonic reactions
Motion sickness

(Can worsen BPH, constipation, dementia, glaucoma)
148
Cough/Cold in Children <12
Avoid Codeine (FDA)
149
Cough/Cold in Children <6
Avoid all OTC cough/cold products (AAP)
150
Cough/Cold in Children <4
Avoid many OTC cough/cold products (package labeling)
151
Cough/Cold in Children <2
Avoid OTC cough/cold products (FDA)
Avoid Promethazine (FDA)
Avoid topical Menthol + Camphor (package labeling)
152
Cough/Cold Combo Products
D - Decongestant
PE - PhenylEphrine
DM - DextroMethorphan
AC - Codeine
153
Glaucoma Treatment Goal - Decrease IOP
Make less fluid - BB
Move fluid out - Prostaglandin Analogs
Both - Brimonidine
154
Drugs that can Discolor Skin + Secretions
BROWN
ENtacapone
Levodopa
Methyldopa

BROWN/YELLOW
Nitrofurantoin
Metronidazole

ORANGLE/YELLOW
Sulfasalazine

YELLOW-GREEN
Propofol

RED-ORANGE
Phenazopyridine
Rifampin

RED
Anthracyclines

BLUE
Methylene Blue
Mitoxantrone

BLUE-GRAY
Amiodarone
Chloroquine
155
Mild Acne Treatment
FIRST-LINE
Topical BPO and/or Retinoid

ALT
Add topical retinoid or BPO
Switch to another retinoid or topical dapsone
156
Moderate Acne Treatment
FIRST-LINE
Topical combination (BPO, Abx, Retinoid) OR
PO Abx + BPO + topical Retinoid (+/- topical Abx)

ALT
Other combo
Switch PO Abx
Add combined OCP or Spironolactone (F) or Isotretinoin
157
Severe Acne Treatment
FIRST-LINE
Topical combo + PO Abx OR
Isotretinoin

ALT
Switch PO Abx
Add combined OCP or Spironolactone (F) or Isotretinoin
158
FEV1
How much air can be exhaled in 1 sec
159
FVC
After taking deep breath, maximum air that is exhaled
160
FEV1/FVC
Percentage of total air capacity that can be exhaled in 1 sec
Step 1 Asthma Treatment
161
(Intermittent)
PRN LD ICS + Formoterol OR
LD ICS taken with SABA
Step 2 Asthma Treatment
162
(Mild Persistent)
Daily LD ICS OR
PRN ICS + Formoterol

(Alt: LTRA or LD ICS taken w/ SABA)
Step 3 Asthma Treatment
163
(Moderate Persistent)
LD ICS + LABA
Step 4 Asthma Treatment
164
(Severe Persistent)
Medium-dose ICS + LABA

(Alt: HD ICS, add on Tiotropium or LTRA)
Step 5 Asthma Treatment
165
(Severe Persistent)
HD ICS + LABA

(Consider adding: Tiotropium, PO steroid or MABs)
166
MDI
HFA, Respimat, no suffix

Aerosolized liquid medication
Some have propellant (HFA)
Slow + Deep inhalation at same time as pressing canister
SPACER
SHAKE WELL
(except QVar Redihaler, Alvesco, Respimats)
167
DPI
Diskus, Ellipta, Pressair, Handihaler, Neohaler, RespiClick, Flexhaler

Powdered medication
No propellant
Quick + Forceful inhalation
NO Spacer
DO NOT shake
NO priming (except first use of Flexhaler)
COPD vs Asthma
168
Age
>40 vs. <40
COPD vs Asthma
169
Smoking History
>10 years vs. Uncommon
COPD vs Asthma
170
Sputum Production
Common vs. Infrequent
COPD vs Asthma
171
Allergies
Uncommon vs. Common
COPD vs Asthma
172
Symptoms
Persistent vs. Intermittent/Variable
COPD vs Asthma
173
Disease Process
Progressive vs. Stable (does not worsen with time)
COPD vs Asthma
174
Exacerbations
Common complication
COPD vs Asthma
175
First-line treatment
Bronchodilators vs. ICS
176
Group A COPD Treatment
SABA or SABA PRN,
LABA or LAMA
177
Group B COPD Treatment
LAMA or LABA
178
Group C COPD Treatment
LAMA
179
Group D COPD Treatment
LAMA OR
LAMA + LABA (highly symptomatic) OR
LABA + IOS (eosinophilia)
Treatment Considerations for Tobacco Cessation
180
(Meds should be offered to all unless CI, pregnant, or adolescent)
WEIGHT GAIN
Gum, Lozenge, Bupropion delay wt gain

DEPRESSION
Bupropion

DENTURES
Avoid Gum

COST
Avoid Rx only

SKIN CONDITION
Avoid Patch

ASTHMA/COPD
Avoid Inhaler or Spray
181
Diabetes Goals in Pregnancy
FG <95
1h PPG <140
2h PPG <120
182
Diagnosis of Pre-Diabetes
FG 100-125
2h PPG 140-199
A1c 5.7-6.4%
183
DIagnosis of Diabetes
FPG >126
2h PPG >200
A1c >6.5%
184
Complications of Diabetes
MICROvascular
Retinopathy
Diabetic Kidney Disease
Peripheral Neuropathy
Autonomic Neuropathy

MACRvascular
CAD
Cerebrovascular
PAD
185
Adult Diabetes Treatment Goals
A1c <7%
FG 80-130
PPG <180
186
Diabetes Treatment (First-line)
Lifestyle mod + Metformin

A1c 8.5% --> Dual Tx
A1c 10% --> Insulin
187
DM add-on in ASCVD
GLP-1 Agonist (Lira, Sema, Exen)

SGLT2-I (Empa, Cana)
188
DM add-on in HF
SGLT2-I (Empa, Cana)

If CI, GLP-1 (Lira, Sema, Exen)
189
DM add-on to Reduce Hypoglycemia
DPP-4
GLP-1
SGLT2
TZD
190
DM add-on to Promote Weight Loss
GLP1
SGLT2
191
DM add-on to Minimize Cost
SU
TZD
192
Concentrated Insulin Products
Humalog Kwikpen 200 U/mL
Humulin R U-500
Tresiba Flextouch 200 U/mL
Toujeo Solostar 300 U/ml
193
Initiating Basal-Bolus Insulin in T1DM
1. TDD = 0.5 U/kg/day (TBW)
2. 50% bolus + 50% basal
3. Divide bolus by 3 meals
194
Initiating Basal Insulin in T2DM
0.1-0.2 U/kg/day (TBW) OR
10 U/day
195
Insulin conversions
All 1:1 EXCEPT

NPH bid --> Glargine (use 80% of NPH dose)

Toujeo --> Basaglar or Lantus (80% of dose)
196
Diabetes injections without needles included
FlexPen
KwikPen
FlexTouch
SoloStar

Byetta, Victoza, Adlyxin
SymlinPen
197
Treatment of Hyperglycemic Crises
FLUIDS
Start with NS
When BG = 200 --> D5W1/2NS

REGULAR INSULIN INFUSION
0.1 U/kg bolus --> 0.1 U/kg/h OR
0.14 U/kg/h

PREVENT HYPOK

TREAT ACIDOSIS (only if pH <6.9)
Selecting DM Drug Tx
198
Biggest A1c decrease
Insulin
Metformin
SU
TZDs
GLP1
Selecting DM Drug Tx
199
Greatest Hypoglycemia risk
Insulin
Meglitinides
SU
Pramlintide (w/ insulin(
Selecting DM Drug Tx
200
Cardiac benefits
Cana/Empagliflozin
Lira/Semaglutide, Exenatide
Selecting DM Drug Tx
201
Most likely to cause Weight Gain
Insulin
SU
Meglitinides
TZDs
Selecting DM Drug Tx
202
Most likely to cause Weight Loss
SGLT2
GLP1
Pramlintide
Selecting DM Drug Tx
203
Cheapest
Metformin
SU
TZDs
Selecting DM Drug Tx
204
Injectables
Insulin
GLP1
Pramlintide
205
S/Sx of Hypothyroidism
Cold intolerance
Dry skin
Fatigue, Weakness
Muscle cramps, Myalgia
Voice changes
Weight gain
Depression
Bradycardia
Coarse hair (or hair loss)
Menorrhagia
Mental/Memory impairment
Goiter
206
Levothyroxine Tablet Colors
Orangutans Will Vomit On You Right Before They Become Large Proud Giants

25 Orange
50 White
75 Violet
88 Olive
100 Yellow
112 Rose
125 Brown
137 Turquoise
150 Blue
175 Lilac
200 Pink
300 Green
207
S/Sx of Hyperthyroidism
Heat intolerance
Weight loss
Agitation, Anxiety
Palpitations + Tachycardia
Fatigue + Muscle weakness
Frequent BM
Insomnia
Tremor
Thinning hair
Exophthalmos, Diplopia
Light or absent menstruation
Goiter
208
S/Sx of Thyroid Storm
Fever (>103F)
Tachycardia
Tachypnea
Dehydration, Profuse sweating
Agitation, Delirium, Psyschosis
Coma
209
Patients on Steroids are considered Immunosuppressed when:
Taking 2 mg/kg/day or 20 mg/day of Prednisone for >2 wks

Tapering methods include dec. by 10-20%/d over 7-14 d
210
Drugs that cause or worsen Reynaud's
BB
Bleomycin, Cisplatin
Sympathomimetics
211
Contraceptive Boxed Warnings
All E-containing:
Women >35 yo who smoke

E + P TD Patch:
Risk of VTE

Depo-Provera:
Loss of BMD with prolonged use
212
Do not use estrogen with these conditions:
DVT/PE, Stroke, CAD
Breast, Ovarian or Liver cnacer
Liver disease
Uncontrolled HTN
Migraines w/ Aura
213
Severe + Rare ADRs with Estrogen
ACHES

Abdominal pain (severe) - liver problems, ectopic pregnancy

Chest pain - MI, PE

Headaches (severe + vomiting or weakness) - stroke

Eye problems - clot in eye

Swelling/Sudden leg pain - DVT
214
Infertility drugs act like endogenous hormones to trigger ovulation
Clomiphene acts like Estrogen --> Inc. LH/FSH

Gonadotropins act like LH, FSH, hCG --> ovulation
215
Patient Characteristics with Osteoporosis Risk
Advanced age
Ethnicity (Caucasian + Asian)
Family history
Females
Low body weight
216
Medical Conditions with Osteoporosis Risk
Anorexia
DM
GI disease
Hyperthyroidism
Hypogonadism
Menopause
RA, Autoimmune diseases
Epilepsy
HIV
Parkinson
217
Lifestyle Factors with Osteoporosis Risk
Smoking
Excess alcohol intake
Low Ca or Vit D intake
Physical inactivity
218
Medications with Osteoporosis Risk
Anticonvulsants
Aromatase inhibitors
Depo-Medroxyprogesteron
GnRH Agonists
Lithium
PPIs
Steroids (5+ mg prednisone for 3+ mo)
Thyroid hormones 9excess)
Heparin
Loops
SSRIs
TZDs
219
Who should have T-scores measured?
Women 65+ and Men 70+
Younger pts at-risk for fracture
220
Interpreting T-score results
Normal = >-1
Osteopenia = -1 to -2.4
Osteoporosis = <-2.5
221
Calcium RDI
1,000 - 1,200 mg elemental

(Do not exceed 500-600 mg elemental per dose)
222
Calcium Formulations
Carbonate = 40% Ca
Acid-dependent
Must take with meals

Citrate = 21% Ca
NOT acid-dependent
Take w/ or w/o meals
223
Vitamin D
Deficiency <30 ng/mL

Treat with D2 or D3
5,000-7,000 IU qd or 50,000 IU qwk
224
Criteria for Initiating Osteoporosis Tx
OSTEOPOROSIS
PM women or men >50 + T-score <-2.5 OR
Presence of fragility Fx

OSTEOPENIA
T-score -1 to -2.5 AND FRAX >20% MOF or 3% Hip
225
Hormone Therapy - Estrogens
Most effective for Vasomotor Sx

If women has uterus --> USE PROGEST COMBO

Significant warnings for VTE, stroke, dementia, breast cancer
226
Hormone Therapy - Progestins
Mood disturbances
If taken intermittently --> Spotting

Micronized considered safer than synthetic
227
Criteria for Use of Hormone Therapy
Healthy, symptomatic women (w/i 10 yrs menopause) aged <60

Extending Tx beyond 60 may be ok if lowest possible dose and awareness of safety rosks
228
When to Reduce Dose of PDE5 Inhibitor
Age 65+
Using an alpha-blocker
CYP3A4 inhibitor
Severe renal or liver disease
229
Anticholinergic Side Effects
PERIPHERAL
Dry mouth
Dry eyeslurred vision
Urinary retention
Constipation

CENTRAL
Sedation
Dizziness
Cognitive impairment
230
Decreasing Dry Mouth with Anticholinergics
Extended-release
Oxybutynin Gel or Patch
Mirabegron
"Renal Dose" Dopamine
231
(D1)
1-4 mcg/kg/min
Medium-Dose Dopamine
232
(B1)
5-10 mcg/kg/min
High-Dose Dopamine
233
(a1)
10-20 mcg/kg/min
234
Treating ADHF
VOLUME OVERLOAD
Loop diuretics
Vasodilators (may be added)

HYPOPERFUSION*
Inotropes (dobutamine, milrinone)
Vasopressor (if HoTN)

*Avoid vasodilators
Avoid in Pediatrics
235
(Contraindicated)
Codeine <12 yrs
Tramadol <12 yrs
Promethazine <2 yrs
Ceftriaxone in neonates
Avoid in Pediatrics
236
(Not generally recommended)
Quinolones
Tetracyclines <8 yrs
Benzocaine (teething) <2 yrs
OTC cough/cold <6 yrs (AAP)
237
Inhaled Medications for CF
1. Bronchodilators
2. Hypertonic Saline
3. Dornase alfa
4. Chest physiotherapy
5. Abx
238
Common Issues with Pancreatic Enzyme Products
Formulations are NOT interchangeable

Viokace is the only tablet (non-EC + must be given w/ PPI)

All others are CAPSULES (DR caps may be sprinkled on acidic foods)

Take with all meals + snacks (50% meal dose)

Protect from moisture + do NOT refrigerate
239
Induction Immunosuppressants
Basiliximab
Antithymocute globulin (higher risk pts)
Maintenance drugs a higher doses
240
Maintenance Immunosuppressants
CNIs - Tacrolimus* or Cyclosporine

ADJUVANTS
Antiproliferative - Mycophenolate or Azathioprine
mTORI - Evero/Sirolimus
Belatacept

STEROIDS
241
Infection Risk Reduction in Transplant
Pts must self-monitor

Ppx Abx are likely

Treat OI (like in HIV)
242
Adverse Events with Maintenance Immunosuppressants
NEPHRO - Tacrolimus + Cyclosporine
DM - Tacrolimus, Cyclosporine + Steroids
LIPIDS - mTORI, Cyclosporine + Steroids
HTN - Tacrolimus, Cyclosporine + Steroids
243
Vaccines in Transplant Patients
Required vaccines should be given pre-transplant

INactivated vaccines can be given 3-6 mo after

Live vaccines are CI
244
Vaccine-preventable Illnesses in Transplant
INFLUENZA annually

PNEUMOCOCCAL (>19 yo)
PCV13 1st (if never received)
PPSV23 (8 wks later --> 5 yrs later)

VARICELLA (high risk for severe)
Vaccinate pre-transplant _ vaccinate close contacts
245
Weight Loss Agents in Pregnancy
AVOID ALL
246
Weight Loss Agents in HTN
AVOID
Contrave (bup/nal)

CAUTION
Qsymia (phen/top)
247
Weight Loss Agents in Depression
Avoid Contrave in YA/Adolescents
248
Weight Loss Agents in Seizures
AVOID
Contrave (bup/nal)

CAUTION
Qsymia (phen/top)
249
Weight Loss Agents in Opioid Users
AVOID
Contrave (bup/nal)
250
NAC for APAP Overdose
Restores intracellular glutathione

Available PO + IV
251
Opioid ALlergy
Common drugs in same chemical class have -COD or -MORPH in the name

CODeine, hydro/oxyCODone
MORPHine, hydro/oxyMORPHone
bupreNORPHine

(Tramadol has warning of cross-rxn)
252
Opioid-induced Constipation
Does not improve over time w/o Tx

1st-line - Stimulant laxatives +/- Stool softener
2nd-line - PAMORAS
3rd-line - Lubiprostone
253
Dosing Considerations for Bleomycin
Lifetime dose = 400 U

Pulmonary toxicity
254
Dosing Considerations for Doxorubicin
Lifetime dose = 450-550 mg/m2

Cardiotoxicity
255
Dosing Considerations for Cisplatin
Dose per cycle = 100 mg/m2

Nephrotoxicity
256
Dosing Considerations for Vincristine
Single dose = 2 mg

Neuropathy
257
Chemoman
258
Adjunct for Cisplatin
Amifostine

(Nephro)
259
Adjunct for Doxorubicin
Dexrazoxane

(Cardiomyopathy + Tx for extravasation)
260
Adjunct for Fluorouracil
Leucovorin

(Enhance efficacy)
261
Adjunct for Fluorouracil or Capecitabine
Uridine triacetate

(Antidote)
262
Adjunct for Ifosfamide
Mesna

(Hemorrhagic cystitis)
263
Adjunct for Irinotecan
Atropine
(Acute diarrhea [prevent or Tx])

Loperamide
(Delayed diarrhea)
264
Adjunct for Methotrexate
Leucovorin, Glucarpidase

(Given AFTER MTX to dec. myelosuppression, with mucositis [antidote], and with ARF)
265
Cycle-Independent Chemo
All Awesome Pharmacists

Alkylating
Anthracyclines
Platinums
266
Mitosis Chemo
Tax My Vin!

Taxanes
Vinca
267
S-phase Chemo
AT the S-phase, DNA replicATes

Antimetabolites
Topoisomerase I Inhibitors
268
G1/G2-phase Chemo
1 SIA, 2 Tops

G1 - Steroids, IFNs, Asparaginase
G2 - Topoisomerase II Inhibitors
BevaCIzumab, RamuCIrumab
269
(Ci - Circulatory)
Target = VEGF
Inhibits BV growth (solid tumors, NSCLC + colon)

HTN --> Proteinuria
Hemorrhage + Thrombosis
Impaired wound healing
CeTUximab, PaniTUmumab
270
(Tu - Tumor)
Cet EGgs in Pan

Target = EGFR
Inhibits GF from binding to tumor (solid tumors, colon)

EGFR --> epidermis --> Skin toxicity
(rash correlated with response to Tx)
TrasTUzumab, PerTUzumab
271
(Tu - Tumor)
Per Trust, HER2

Target = HER2
Inhibits GF from binding to tumor (BC)

Cardiotoxicity
Fetal toxicity
RiTUximab, BrenTUximab, DaraTUmumab, InoTUzumab
272
(Tu - Tumor)
RIBD CDs

Target = CD antigens
Hematologic malignancies
(Bren vedotin is ADC for CD30 (HL))

BM suppression

Ino ozogamicin + Bren vedotin are ADC
IpiLImumab, AtezoLIzumab, NioLumab, PembroLIzumab
273
(Li - Immune system)
Target = IS (PD1, PDL1, CTLA4)
Increased immune recognition (solid tumors, NSCLC + melanoma)

Immune-mediated rxns --> Colitis, Hepatotoxicity, Thyroid, Myocarditis
274
BRAF Inhibitors
-RAF
275
MEK Inhibitors
MET
276
EGFR Inhibitors (NSCLC)
a Lot of Fats Get fit

Erlotinib
Afatinib
Gefitinib
277
ALK Inhibitors
Alect Cray Cray ALKs

Alectinib
Cerotinib
Crizotinib
278
Depression Diagnosis
MSIGECAPS

Mood - Depressed
Sleep - Inc./Dec.
Interest - Diminished
Guilt or Worthlessness
Energy - Dec.
Concentration - Dec.
Appetite - Inc./Dec.
Psychomotor agitation or retardation
Suicidality
Tertiary TCA
279
(Less selective, but more effective)
Ami TrICles Down 3 rungs

Amitriptyline
Trimipramine
Clomipramine
Imipramine
Doxepin
280
Depression Tx - Trying to avoid weight gain
Avoid Mirtazapine
Consider Bupropion
281
Depression Tx - Pt with cardiac issues
Avoid Citalopram, Escitalopram
Consider Sertraline
282
Depression Tx - At risk for seizures or anorexiaulimia
Bupropion is CI
Do not exceed 450 mg/d
283
Depression Tx - Trying to avoid sexual dysfunction
Avoid SSRIs + SNRIs
Consider Bupropion + Mirtazapine
284
Depression Tx - Pt w/ insomnia = low BW
Consider Mirtazapine
285
Depression Tx - Pt w/ pain
Consider Duloxetine
286
AP + EPS risk
LOW - Quetiapine
HIGH - FGA, Ris/Paliperidone
287
AP + Metabolic risk
LOW - FGA, Aripiprazole, Zip/Lurasidone, Asenapine
MOD - Ris/Paliperidone
HIGH - Clozapine, Olanzapine, Quetiapine
288
AP + QT risk
HIGH - Thioridazine, Haloperidol, Ziprasidone
289
AP + Hematologic risk
Clozapine (agranulocytosis)
290
AP + Prolactinemia risk
Ris/Paliperidone
291
AP + Seizure risk
Clozapine
292
Mania Diagnosis
Distractibility
Insomnia
Grandiosity
Flight of Ideas
Activity (goal-oriented(
Speech (pressured)
Talkativeness
293
Patient-friendly Formulations for Stimulants
SUSPENSION
Quillivant XR, Dyanavel XR, Adzenys ER

CHEWABLE TAB
QuilliChew ER, Vyvanse

CAPSULE (SPRINKLABLE)
Focalin XR, Ritalin LA, Aptensio XR, Adderall XE

CAPSULE (MIX W/ WATER, OJ, YOGURT)
Vyvanse

ODT
Cotempla XR, Adzenys XR

PATCH
Daytrana
294
Un-CLAD Anxiety
Clonaz
Loraz
Alpraz
Diaz
295
Help Falling Asleep
Eszopiclone
Zolpidem

Zaleplon
Ramelteon
Help Staying Asleep
296
(EXtend your sleep)
Eszopiclone
Zolpidem

Suvorexant
Doxepin
297
Motor Symptoms of Parkinson's
TRAP

Tremor (at rest)
Rigidity
Akinesia/Bradykinesia
Postural instability
298
Additional Parkinson's Symptoms
Micrographia
Shuffling walk
Muffled speech, Drooling, Dysphagia
Depression, Anxiety, Psychosis
Constipation, Incontinence
299
Status Epilepticus Treatment
0-5 MIN
Time the seizure, start EEG, O2
Check E-lytes, [AED], BG

5-20 MIN
IV Lorazepam
IM Midaz, Rectal Diaz

20-40 MIN
IV Fosphenytoin, VPA, Levetiracetam
(Phenobarbital if others unavailable)
300
Broad Spectrum AEDs
Brian Leaves Lambs To Val

Levetiracetam
Lamotrigine
Topiramate
Valproate

20 more cards in OutLearn. Open the full deck

Study all 320 cards for free